Spiriva respimat and Lymph node calcification - a phase IV clinical study of FDA data

Summary:

Lymph node calcification is reported as a side effect among people who take Spiriva respimat (tiotropium bromide), especially for people who are female, 60+ old, also take Nucala,.

The phase IV clinical study analyzes which people have Lymph node calcification when taking Spiriva respimat. It is created by eHealthMe based on reports of 9,653 people who have side effects when taking Spiriva respimat from the FDA, and is updated regularly.

What is Spiriva respimat?

Spiriva respimat has active ingredients of tiotropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 9,788 Spiriva respimat users. Check the latest studies of Spiriva respimat.

What is Lymph node calcification?

Lymph node calcification (calcium deposit in lymph node) is found to be associated with 77 drugs and 176 conditions by eHealthMe. Check the latest studies of Lymph node calcification.

On Jul, 25, 2026

9,653 people reported to have side effects when taking Spiriva respimat.
Among them, 20 people (0.21%) have Lymph node calcification.

Could Spiriva respimat cause Lymph node calcification?

Among these 20 people:

What is the gender of people who have Lymph node calcification when taking Spiriva respimat? *

female: 100 %
male: 0.0 %

What is the age of people who have Lymph node calcification when taking Spiriva respimat? *

What are other drugs people take besides Spiriva respimat? *

What are other side effects people have besides Lymph node calcification? *

Vision Blurred: 20 people, 100.00%
Productive Cough: 20 people, 100.00%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 20 people, 100.00%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 20 people, 100.00%
Dyspnea (difficult or laboured breathing): 20 people, 100.00%
Chest Pain: 20 people, 100.00%
Broncholithiasis (bronchial inflammation or obstruction caused by calculi in the bronchi): 20 people, 100.00%
Bronchial Wall Thickening: 20 people, 100.00%
Back Pain: 20 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Spiriva respimat and have Lymph node calcification?

- Check whether Lymph node calcification is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Spiriva respimat:

Spiriva respimat (9,788 reports)

Browse all side effects of Spiriva respimat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lymph node calcification:

Lymph node calcification (77 drugs)

Browse all the conditions that are associated with Lymph node calcification:

Lymph node calcification (176 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tiotropium bromide (the active ingredients of Spiriva respimat) and Spiriva respimat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.